Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127123311 | 12712331 | 1 | I | 20160709 | 20160831 | 20160902 | 20160902 | EXP | CO-ABBVIE-16P-036-1716936-00 | ABBVIE | 44.05 | YR | M | Y | 80.00000 | KG | 20160902 | MD | COUNTRY NOT SPECIFIED | CO |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127123311 | 12712331 | 1 | PS | ZEMPLAR | PARICALCITOL | 1 | Oral | UNKNOWN | 21606 | 4 | UG | CAPSULE | QD | ||||||
127123311 | 12712331 | 2 | C | VERAPAMIL | VERAPAMIL HYDROCHLORIDE | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127123311 | 12712331 | 1 | Hyperparathyroidism secondary |
127123311 | 12712331 | 2 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127123311 | 12712331 | DE |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127123311 | 12712331 | Device related sepsis |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127123311 | 12712331 | 1 | 20130913 | 20160531 | 0 |